Radioconjugates: Targeting for Precision
The development of radioconjugates – targeted molecules designed to carry radionuclides directly to cancerous cells, lowering systemic exposure and increasing the precision of treatment.
May 6, 2025
by Suzanne Elvidge
Now and Next in Type 2 Diabetes
Type 2 diabetes, the most common form of diabetes, affects more than 800 million adults worldwide.
May 6, 2025
by Suzanne Elvidge
Oncolytic viruses in cancer treatment
Naturally occurring oncolytic viruses, which replicate in tumour cells and trigger apoptosis and immune responses while sparing healthy cells, were first discovered at the turn of the 19th century.
April 21, 2025
by Suzanne Elvidge